Trial · NCT01380197
Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally
NCT01380197, Phase 3, Completed, Children's Healthcare of Atlanta; results first posted 2015-02-16
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally. Trials, record NCT01380197. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01380197
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally
- NCT number
- NCT01380197
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 40 participants, actual
- Lead sponsor
- Children's Healthcare of Atlanta
- Conditions
- Pain, Sickle Cell Disease
- Interventions
- Morphine, Nubain
- First posted
- 2011-06-27
- Last updated
- 2018-02-20
- Results first posted
- 2015-02-16
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Acute Chest Syndrome | 3 days | Number of Participants with Acute Chest Syndrome or A new pulmonry infiltrate on Chest X-ray |
| Secondary | Number of Participants Who Experienced Pain Relief | 2 days |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Acute Chest Syndrome | 3 days | participants | NUMBER | |
| SECONDARY | Number of Participants Who Experienced Pain Relief | 2 days | participants | NUMBER |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Acute Chest Syndrome | Randomizing Particiipants to Morphine | 2 | participants | ||
| Acute Chest Syndrome | Randomization to Nubain | 1 | participants | ||
| Number of Participants Who Experienced Pain Relief | Randomizing Particiipants to Morphine | 2 | participants | ||
| Number of Participants Who Experienced Pain Relief | Randomization to Nubain | 2 | participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Randomizing Particiipants to Morphine | 20 | |
| Overall Study | STARTED | Randomization to Nubain | 20 | |
| Overall Study | COMPLETED | Randomizing Particiipants to Morphine | 20 | |
| Overall Study | COMPLETED | Randomization to Nubain | 20 | |
| Overall Study | NOT COMPLETED | Randomizing Particiipants to Morphine | 0 | |
| Overall Study | NOT COMPLETED | Randomization to Nubain | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Randomizing Particiipants to Morphine | ||
| Total, all-cause mortality | Randomization to Nubain | ||
| Total, other adverse events | Randomizing Particiipants to Morphine | 0 | 20 |
| Total, other adverse events | Randomization to Nubain | 0 | 20 |
| Total, serious adverse events | Randomizing Particiipants to Morphine | 0 | 20 |
| Total, serious adverse events | Randomization to Nubain | 0 | 20 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons3
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Randomizing Particiipants to Morphine vs Randomization to Nubain: Number of Participants Who Experienced Pain Relief | Trial comparisons |
| Randomizing Particiipants to Morphine vs Randomization to Nubain: Acute Chest Syndrome | Trial comparisons |
| Randomizing Particiipants to Morphine vs Randomization to Nubain: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01380197
GET https://conductscience.org/api/trials/v1/NCT01380197/registered